The OptimaMed intervention to reduce medication burden in nursing home residents with severe dementia: results from a pragmatic, controlled study.
Dementia
Deprescribing
Inappropriate medication
Nursing home
OptimaMed
Journal
BMC geriatrics
ISSN: 1471-2318
Titre abrégé: BMC Geriatr
Pays: England
ID NLM: 100968548
Informations de publication
Date de publication:
28 08 2023
28 08 2023
Historique:
received:
05
10
2022
accepted:
07
08
2023
medline:
31
8
2023
pubmed:
29
8
2023
entrez:
28
8
2023
Statut:
epublish
Résumé
Nursing home (NH) residents with severe dementia use many medications, sometimes inappropriately within a comfort care approach. Medications should be regularly reviewed and eventually deprescribed. This pragmatic, controlled trial assessed the effect of an interprofessional knowledge exchange (KE) intervention to decrease medication load and the use of medications of questionable benefit among these residents. A 6-month intervention was performed in 4 NHs in the Quebec City area, while 3 NHs, with comparable admissions criteria, served as controls. Published lists of "mostly", "sometimes" or "exceptionally" appropriate medications, tailored for NH residents with severe dementia, were used. The intervention included 1) information for participants' families about medication use in severe dementia; 2) a 90-min KE session for NH nurses, pharmacists, and physicians; 3) medication reviews by NH pharmacists using the lists; 4) discussions on recommended changes with nurses and physicians. Participants' levels of agitation and pain were evaluated using validated scales at baseline and the end of follow-up. Seven (7) NHs and 123 participants were included for study. The mean number of regular medications per participant decreased from 7.1 to 6.6 in the intervention, and from 7.7 to 5.9 in the control NHs (p-value for the difference in differences test: < 0.05). Levels of agitation decreased by 8.3% in the intervention, and by 1.4% in the control NHs (p = 0.026); pain levels decreased by 12.6% in the intervention and increased by 7% in the control NHs (p = 0.049). Proportions of participants receiving regular medications deemed only exceptionally appropriate decreased from 19 to 17% (p = 0.43) in the intervention and from 28 to 21% (p = 0.007) in the control NHs (p = 0.22). The mean numbers of regular daily antipsychotics per participant fell from 0.64 to 0.58 in the intervention and from 0.39 to 0.30 in the control NHs (p = 0.27). This interprofessional intervention to reduce inappropriate medication use in NH residents with severe dementia decreased medication load in both intervention and control NHs, without important concomitant increase in agitation, but mixed effects on pain levels. Practice changes and heterogeneity within these 7 NHs, and a ceiling effect in medication optimization likely interfered with the intervention. The study is registered at ClinicalTrials.gov: # NCT05155748 (first registration 03-10-2017).
Sections du résumé
BACKGROUND
Nursing home (NH) residents with severe dementia use many medications, sometimes inappropriately within a comfort care approach. Medications should be regularly reviewed and eventually deprescribed. This pragmatic, controlled trial assessed the effect of an interprofessional knowledge exchange (KE) intervention to decrease medication load and the use of medications of questionable benefit among these residents.
METHODS
A 6-month intervention was performed in 4 NHs in the Quebec City area, while 3 NHs, with comparable admissions criteria, served as controls. Published lists of "mostly", "sometimes" or "exceptionally" appropriate medications, tailored for NH residents with severe dementia, were used. The intervention included 1) information for participants' families about medication use in severe dementia; 2) a 90-min KE session for NH nurses, pharmacists, and physicians; 3) medication reviews by NH pharmacists using the lists; 4) discussions on recommended changes with nurses and physicians. Participants' levels of agitation and pain were evaluated using validated scales at baseline and the end of follow-up.
RESULTS
Seven (7) NHs and 123 participants were included for study. The mean number of regular medications per participant decreased from 7.1 to 6.6 in the intervention, and from 7.7 to 5.9 in the control NHs (p-value for the difference in differences test: < 0.05). Levels of agitation decreased by 8.3% in the intervention, and by 1.4% in the control NHs (p = 0.026); pain levels decreased by 12.6% in the intervention and increased by 7% in the control NHs (p = 0.049). Proportions of participants receiving regular medications deemed only exceptionally appropriate decreased from 19 to 17% (p = 0.43) in the intervention and from 28 to 21% (p = 0.007) in the control NHs (p = 0.22). The mean numbers of regular daily antipsychotics per participant fell from 0.64 to 0.58 in the intervention and from 0.39 to 0.30 in the control NHs (p = 0.27).
CONCLUSIONS
This interprofessional intervention to reduce inappropriate medication use in NH residents with severe dementia decreased medication load in both intervention and control NHs, without important concomitant increase in agitation, but mixed effects on pain levels. Practice changes and heterogeneity within these 7 NHs, and a ceiling effect in medication optimization likely interfered with the intervention.
TRIAL REGISTRATION
The study is registered at ClinicalTrials.gov: # NCT05155748 (first registration 03-10-2017).
Identifiants
pubmed: 37641020
doi: 10.1186/s12877-023-04222-4
pii: 10.1186/s12877-023-04222-4
pmc: PMC10464023
doi:
Substances chimiques
Antipsychotic Agents
0
Banques de données
ClinicalTrials.gov
['NCT05155748']
Types de publication
Controlled Clinical Trial
Journal Article
Pragmatic Clinical Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
520Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Pain Manag Nurs. 2004 Mar;5(1):37-49
pubmed: 14999652
Can J Aging. 2008 Spring;27(1):45-55
pubmed: 18492636
Age Ageing. 2015 Mar;44(2):213-8
pubmed: 25324330
Ther Adv Drug Saf. 2015 Dec;6(6):212-33
pubmed: 26668713
PLoS One. 2018 Sep 18;13(9):e0203480
pubmed: 30226850
J Am Med Dir Assoc. 2015 Jul 1;16(7):629.e1-17
pubmed: 25979776
Int J Geriatr Psychiatry. 2008 May;23(5):490-6
pubmed: 17944007
Nat Rev Neurol. 2009 May;5(5):245-55
pubmed: 19488082
J Am Med Dir Assoc. 2021 Jan;22(1):141-147
pubmed: 33221164
J Am Med Dir Assoc. 2019 Mar;20(3):362-372.e11
pubmed: 30581126
J Palliat Med. 2013 Jan;16(1):31-7
pubmed: 23234299
Dement Geriatr Cogn Disord. 2015;40(3-4):166-77
pubmed: 26138271
BMC Geriatr. 2018 Sep 4;18(1):204
pubmed: 30180821
Geriatr Gerontol Int. 2020 Mar;20(3):229-237
pubmed: 31858696
JAMA Netw Open. 2021 Aug 2;4(8):e2118441
pubmed: 34338794
PLoS Med. 2008 Apr 1;5(4):e76
pubmed: 18384230
J Am Geriatr Soc. 2014 Nov;62(11):2095-101
pubmed: 25369872
Nurs Stand. 2002 Jul 3-9;16(42):33-8
pubmed: 12216309
Aging Ment Health. 2015;19(9):799-807
pubmed: 25319535
Am J Public Health. 2004 Mar;94(3):361-6
pubmed: 14998794
Arch Gerontol Geriatr. 2006 Mar-Apr;42(2):191-206
pubmed: 16125809
Prog Palliat Care. 2011 Jan;19(1):15-21
pubmed: 21731193
Semin Cancer Biol. 2020 Aug;64:93-101
pubmed: 31330185
Handb Clin Neurol. 2019;167:139-148
pubmed: 31753130
Drugs Aging. 2008;25(11):947-54
pubmed: 18947262
Ther Adv Drug Saf. 2018 Jan;9(1):25-43
pubmed: 29318004
JAMA. 2005 Mar 16;293(11):1348-58
pubmed: 15769968
Drugs Aging. 2013 Sep;30(9):655-66
pubmed: 23749475
West J Emerg Med. 2017 Oct;18(6):1075-1078
pubmed: 29085540
J Am Med Dir Assoc. 2020 Feb;21(2):212-219
pubmed: 31669289
J Am Geriatr Soc. 2020 Dec;68(12):2768-2777
pubmed: 32786002
J Am Geriatr Soc. 2019 Apr;67(4):674-694
pubmed: 30693946
Clin Pharmacol Ther. 2009 Jan;85(1):103-7
pubmed: 19037198
Int J Palliat Nurs. 2013 Feb;19(2):67-74
pubmed: 23435535
Arch Intern Med. 2008 May 26;168(10):1090-6
pubmed: 18504337
BMJ. 2015 Mar 02;350:h369
pubmed: 25731881
Consult Pharm. 2015 Oct;30(10):599-611
pubmed: 26450142
J Am Med Dir Assoc. 2009 Jan;10(1):50-5
pubmed: 19111853
J Am Med Dir Assoc. 2016 Sep 1;17(9):862.e1-9
pubmed: 27473899
Cleve Clin J Med. 2014 Jul;81(7):427-37
pubmed: 24987044
BMJ Open. 2014 Oct 08;4(10):e006082
pubmed: 25296655
J Am Geriatr Soc. 2008 Jul;56(7):1306-11
pubmed: 18482301
Am J Psychiatry. 1982 Sep;139(9):1136-9
pubmed: 7114305
BMC Health Serv Res. 2010 Nov 30;10:321
pubmed: 21118575
J Public Health (Oxf). 2008 Mar;30(1):103-9
pubmed: 18204086
J Gerontol. 1989 May;44(3):M77-84
pubmed: 2715584
Intern Emerg Med. 2022 Jan;17(1):165-171
pubmed: 34546497
J Am Geriatr Soc. 2019 Mar;67(3):455-462
pubmed: 30575952
Int J Environ Res Public Health. 2022 Jun 30;19(13):
pubmed: 35805698
J Am Geriatr Soc. 2010 May;58(5):880-8
pubmed: 20406320
Cochrane Database Syst Rev. 2021 Dec 17;12:CD013304
pubmed: 34918337
J Am Med Dir Assoc. 2013 Nov;14(11):801-8
pubmed: 24074961
Ann Intern Med. 2007 Jun 5;146(11):775-86
pubmed: 17548409
J Clin Med. 2022 Mar 11;11(6):
pubmed: 35329879
Palliat Med. 2018 Mar;32(3):613-621
pubmed: 28731379
Pharmacy (Basel). 2019 Mar 05;7(1):
pubmed: 30841495
Can Fam Physician. 2018 Jan;64(1):17-27
pubmed: 29358245
Ann Intern Med. 2001 Oct 16;135(8 Pt 2):703-10
pubmed: 11601953
Int J Clin Pharm. 2020 Aug;42(4):1153-1167
pubmed: 32494991
Age Ageing. 2008 Nov;37(6):673-9
pubmed: 18829684
J Gerontol Nurs. 2005 Sep;31(9):4-11
pubmed: 16190007